Pantoprazole is a proton-pump inhibitor (PPI) widely used in hospitals and outpatient settings. Pantoprazole has approval from the Food and Drug Administration Agency (FDA) for the treatment of various disease processes, including therapy for erosive esophagitis associatedÂ with gastroesophageal reflux disease and the treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.Helicobacter pylori bacteria and preventing peptic ulcer re-bleeding and/or NSAID-induced ulcers.